Geriatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Savi 10, 56126, Pisa, Italy.
BMC Geriatr. 2020 Dec 22;20(1):539. doi: 10.1186/s12877-020-01963-4.
In late December 2019, a cluster of pneumonia cases due to a novel betacoronavirus, SARS-CoV-2 was reported in China. The so-called COVID 19 is responsible not only for respiratory symptoms, from mild up to pneumonia and even acute respiratory distress syndrome, but also for extrapulmonary involvement.
Here we present two cases of spontaneous muscle hematoma in patients with SARS-CoV-2 infection, both on therapeutic LMWH for atrial fibrillation: the first one was an 86-year-old Caucasian female with a history of hypertensive cardiomyopathy and the second one was an 81-year-old Caucasian male with a history of hypertension, diabetes and ischemic heart disease. Blood tests revealed a considerable drop of hemoglobin and alterations of coagulation system. In both cases, embolization of femoral artery was performed. A few other cases of bleeding manifestations are reported in literature, while a lot has been published about the hypercoagulability related to COVID-19.
Our reports and literature review highlight the need of active surveillance for possible hemorrhagic complications in patients with SARS-CoV-2 infection.
2019 年 12 月下旬,中国报告了一组由新型贝塔冠状病毒 SARS-CoV-2 引起的肺炎病例。所谓的 COVID-19 不仅会导致呼吸系统症状,从轻症到肺炎甚至急性呼吸窘迫综合征,还会导致肺外受累。
这里我们介绍了两例 SARS-CoV-2 感染患者的自发性肌肉血肿病例,均接受低分子肝素治疗心房颤动:第一个是 86 岁的白人女性,有高血压性心肌病病史;第二个是 81 岁的白人男性,有高血压、糖尿病和缺血性心脏病病史。血液检查显示血红蛋白显著下降和凝血系统改变。在这两种情况下,均进行了股动脉栓塞术。文献中还报道了其他一些出血表现的病例,而关于 COVID-19 相关高凝状态的报道则很多。
我们的报告和文献回顾强调了需要对 SARS-CoV-2 感染患者进行积极监测,以发现可能的出血并发症。